These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
357 related articles for article (PubMed ID: 29204272)
1. Novel antibiotic combinations proposed for treatment of El-Halfawy OM; Naguib MM; Valvano MA Antimicrob Resist Infect Control; 2017; 6():120. PubMed ID: 29204272 [TBL] [Abstract][Full Text] [Related]
2. Two case reports of the successful eradication of new isolates of Burkholderia cepacia complex in children with cystic fibrosis. Kitt H; Lenney W; Gilchrist FJ BMC Pharmacol Toxicol; 2016 Mar; 17():14. PubMed ID: 27018049 [TBL] [Abstract][Full Text] [Related]
3. "Switching Partners": Piperacillin-Avibactam Is a Highly Potent Combination against Multidrug-Resistant Zeiser ET; Becka SA; Wilson BM; Barnes MD; LiPuma JJ; Papp-Wallace KM J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31167848 [TBL] [Abstract][Full Text] [Related]
4. Can early Burkholderia cepacia complex infection in cystic fibrosis be eradicated with antibiotic therapy? Horsley A; Webb K; Bright-Thomas R; Govan J; Jones A Front Cell Infect Microbiol; 2011; 1():18. PubMed ID: 22919584 [TBL] [Abstract][Full Text] [Related]
5. Overcoming an Extremely Drug Resistant (XDR) Pathogen: Avibactam Restores Susceptibility to Ceftazidime for Burkholderia cepacia Complex Isolates from Cystic Fibrosis Patients. Papp-Wallace KM; Becka SA; Zeiser ET; Ohuchi N; Mojica MF; Gatta JA; Falleni M; Tosi D; Borghi E; Winkler ML; Wilson BM; LiPuma JJ; Nukaga M; Bonomo RA ACS Infect Dis; 2017 Jul; 3(7):502-511. PubMed ID: 28264560 [TBL] [Abstract][Full Text] [Related]
6. Ceftazidime plasma concentration in a patient with cystic fibrosis treated with ceftazidime/avibactam plus trimethoprim/sulfametoxazole for Saffioti C; Barco S; Cangemi G; Mesini A; Casciaro R; Cresta F; Castellani C; Bandettini R; Morelli P; Castagnola E J Chemother; 2019; 31(7-8):436-438. PubMed ID: 31583970 [No Abstract] [Full Text] [Related]
7. Antimicrobial susceptibility and synergy studies of Burkholderia cepacia complex isolated from patients with cystic fibrosis. Zhou J; Chen Y; Tabibi S; Alba L; Garber E; Saiman L Antimicrob Agents Chemother; 2007 Mar; 51(3):1085-8. PubMed ID: 17158942 [TBL] [Abstract][Full Text] [Related]
8. In vitro efficacy of high-dose tobramycin against Burkholderia cepacia complex and Stenotrophomonas maltophilia isolates from cystic fibrosis patients. Ratjen A; Yau Y; Wettlaufer J; Matukas L; Zlosnik JE; Speert DP; LiPuma JJ; Tullis E; Waters V Antimicrob Agents Chemother; 2015 Jan; 59(1):711-3. PubMed ID: 25348526 [TBL] [Abstract][Full Text] [Related]
12. Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation. Horsley A; Jones AM Cochrane Database Syst Rev; 2012 Oct; 10():CD009529. PubMed ID: 23076960 [TBL] [Abstract][Full Text] [Related]
13. Hypermutation in Burkholderia cepacia complex is mediated by DNA mismatch repair inactivation and is highly prevalent in cystic fibrosis chronic respiratory infection. Martina P; Feliziani S; Juan C; Bettiol M; Gatti B; Yantorno O; Smania AM; Oliver A; Bosch A Int J Med Microbiol; 2014 Nov; 304(8):1182-91. PubMed ID: 25217078 [TBL] [Abstract][Full Text] [Related]
14. Burkholderia cepacia complex infections: More complex than the bacterium name suggest. Sfeir MM J Infect; 2018 Sep; 77(3):166-170. PubMed ID: 30012345 [TBL] [Abstract][Full Text] [Related]
15. Management of initial colonisations with Burkholderia species in France, with retrospective analysis in five cystic fibrosis Centres: a pilot study. Gruzelle V; Guet-Revillet H; Segonds C; Bui S; Macey J; Chiron R; Michelet M; Murris-Espin M; Mittaine M BMC Pulm Med; 2020 Jun; 20(1):159. PubMed ID: 32503487 [TBL] [Abstract][Full Text] [Related]
16. Novel glycopolymer sensitizes Burkholderia cepacia complex isolates from cystic fibrosis patients to tobramycin and meropenem. Narayanaswamy VP; Giatpaiboon S; Baker SM; Wiesmann WP; LiPuma JJ; Townsend SM PLoS One; 2017; 12(6):e0179776. PubMed ID: 28662114 [TBL] [Abstract][Full Text] [Related]
17. Burkholderia cepacia complex infection in adult patients with cystic fibrosis--is early eradication possible? Etherington C; Peckham DG; Conway SP; Denton M J Cyst Fibros; 2003 Dec; 2(4):220-1. PubMed ID: 15463878 [No Abstract] [Full Text] [Related]
18. Multiple combination bactericidal antibiotic testing for patients with cystic fibrosis infected with Burkholderia cepacia. Aaron SD; Ferris W; Henry DA; Speert DP; Macdonald NE Am J Respir Crit Care Med; 2000 Apr; 161(4 Pt 1):1206-12. PubMed ID: 10764313 [TBL] [Abstract][Full Text] [Related]
19. Use of the E test to assess synergy of antibiotic combinations against isolates of Burkholderia cepacia-complex from patients with cystic fibrosis. Manno G; Ugolotti E; Belli ML; Fenu ML; Romano L; Cruciani M Eur J Clin Microbiol Infect Dis; 2003 Jan; 22(1):28-34. PubMed ID: 12582741 [TBL] [Abstract][Full Text] [Related]
20. Infection with Burkholderia cepacia complex bacteria and pulmonary exacerbations of cystic fibrosis. St Denis M; Ramotar K; Vandemheen K; Tullis E; Ferris W; Chan F; Lee C; Slinger R; Aaron SD Chest; 2007 Apr; 131(4):1188-96. PubMed ID: 17426227 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]